The changes to Insulet's Omnipod algorithm are intended to give users greater control over their insulin management. Image credit: Butusova Elena via Shutterstock.com. Insulet has secured US Food and ...

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...

Insulet Corporation reported revenue of $783.8 million for the fourth quarter of 2025, an increase of 31% over the same period a year prior and ahead of the company’s guidance in the ...

Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United ...

In early February 2026, Insulet announced that its Omnipod 5 Automated Insulin Delivery System and new Omnipod Discover data platform are now available across Saudi Arabia, Kuwait, Qatar, and the UAE, ...

Omnipod 5 has been a major revenue catalyst for Insulet since its release. At the same time, operating expenses associated with Omnipod 5 are higher because of demand exceeding expectations. Higher ...

(RTTNews) - Insulet (PODD) announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. The new 100 mg/dL Target Glucose expands ...

Insulet plans to introduce Omnipod Discover in its Middle Eastern markets first, then expand to other countries where Omnipod ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates, compatible with Abbott and Dexcom continuous glucose sensors ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...